	Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer Meirson T, Mutti L, Goldstein DA, Barkan T, Mutai R, Markel G, Goldman A, Cosmai L, Rizzo M, Porta C. PMID: 42135107 [PubMed - as supplied by publisher]
	Osteoporosis knowledge, health beliefs, and self-efficacy in UK men with prostate cancer: a cross-sectional primary care survey. Br J Gen Pract Huang Q, Oliver P, Evans J, Brown J, Mitchell C. PMID: 42134941 [PubMed - indexed for MEDLINE]
	Prostate-specific antigen (PSA) test for prostate cancer screening. Cochrane Database Syst Rev Franco JV, Hwang EC, Jung JH, Vaimberg O, Ilic D, Cleves A, Dahm P. PMID: 42134821 [PubMed - indexed for MEDLINE]
	Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional non-inferiority phase 3 trial (PCS-XI, NCT05820633). Radiother Oncol Fabi F, Crook J, Jolicoeur M, Rauth S, Koll W, Tisseveransinghe S, Ebacher A, Niazi T, Duplan D, Bernard AA, Vavassis P, Foster W, Vigneault É, Archambault L, Beaulieu L, Lavallée MC, Lacroix F, Carignan D, Martin AG. PMID: 42134662 [PubMed - as supplied by publisher]
	NCCN GuidelinesÂ® Insights: Prostate Cancer, Version 5.2026. J Natl Compr Canc Netw Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, Chapin B, Cheng HH, Cho SY, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Ippolito JE, Karnes RJ, Kishan AU, Kuettel MR, Lang JM, Lee D, Lotan T, McDonald A, Morgan TM, Pessoa R, Rais-Bahrami S, Roach M 3rd, Robin T, Rosenfeld S, Scarpato KR, Seibert T, Shabsigh A, Szmulewitz R, Teply BA, Tward J, Valicenti R, VanderWeele D, Wong JK, Kovach E, Freedman-Cass D. PMID: 42134408 [PubMed - indexed for MEDLINE]
	Perioperative Systemic Treatment Options for Muscle-Invasive Bladder Cancer. J Natl Compr Canc Netw Brown JR, Parikh M. PMID: 42134402 [PubMed - indexed for MEDLINE]
	How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer. Am Soc Clin Oncol Educ Book Richardson N, Tewari AK, Giannatempo P, Basin MF, Nuzzo A, Mascaro F, Feldman DR, Adra N, Daneshmand S. PMID: 42133890 [PubMed - indexed for MEDLINE]
	[Â¹â¸F]PSMA-1007 PET/CT in biochemical recurrence after radical prostatectomy: A single-center experience of detection rate and lesion distribution. PLoS One Wang Y, Feng L, He L, Liu N, Wang H. PMID: 42133652 [PubMed - indexed for MEDLINE]
	UBE2S emerges as a key driver in an NK cell-based prognostic model for clear cell renal cell carcinoma. PLoS One Leng K, Zhou Y, Zhao J, Wang X, Song H. PMID: 42133651 [PubMed - indexed for MEDLINE]
	Single-port EDGE SP1000 versus multi-port Da Vinci Xi robot-assisted radical prostatectomy: a comparative analysis of technique and perioperative outcomes. J Robot Surg Zhang J, Zhou L, Li H, Du H, Wang H, Tai S, Liang C. PMID: 42133277 [PubMed - indexed for MEDLINE]
	A Bioinspired Three-Dimensional High-Curvature Nano-Interface Integrated Microfluidic Chip for Small Extracellular Vesicles Enrichment and Machine Learning-Assisted Prostate Cancer Precision Diagnosis. Adv Sci (Weinh) Wang L, Liang Y, Sulaiman M, Du J, Jiang M, Wang Z, Yu X, Xu L. PMID: 42133268 [PubMed - as supplied by publisher]
	The role of extracellular vesicles-associated proteins markers in prostate cancer: a review. Discov Oncol Said DS, Abdullah MNH, Nurdin A. PMID: 42133214 [PubMed - as supplied by publisher]
	APOE Îµ2/Îµ3 is associated with multi-layered protection against prostate cancer in Chinese men. World J Urol Wang K, Zhang S, Chen M, Duan X, Xie Y, Yang X, Zhong Y, Yu P, Yang M, Wei Z, Tao Z, Liu W. PMID: 42133096 [PubMed - indexed for MEDLINE]
	Chemotherapy-induced anemia as a prognostic factor for overall survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy and cystectomy. World J Urol Lafitte E, Sfumato P, Walz J, Billon E, Branger N, Vicier C, Rybikowski S, Guérin M, Maubon T, Beaufils M, Seguin L, Salem N, Brunelle S, Pignot G, Gravis G. PMID: 42132947 [PubMed - indexed for MEDLINE]
	Toward multimodal integration of colorectal cancer and chronic kidney disease: transcriptomic modeling as a framework for the SIRIO study "Spatial radiomics and transcriptomics to the discovery of the cross-link between colon cancer and chronic kidney disease". Radiol Oncol Fusco R, Granata V, Belli A, F Perna A, Capasso G, Caraglia M, Pace U, Delrio P, Docimo L, Gambardella C, Lucido FS, Floris M, Locci G, Runfola M, Giannascoli D, Izzo M, Sorgente E, Borriello M, Izzo F, Simeoni M, Petrillo A, SIRIO Trial Collaborators. PMID: 42132448 [PubMed - as supplied by publisher]
	Interobserver variability in dominant intraprostatic lesion delineation using (68)Ga-PSMA PET/CT for localized prostate cancer. Rep Pract Oncol Radiother Devran BZ, Cetin IA, Cagliyan F, Özgüven S, Öne. PMID: 42131465 [PubMed]
	Not all masses are metastases: a diagnostic dilemma resolved - synchronous HER2-positive breast cancer and renal oncocytoma. Int J Surg Case Rep Shrivastava N, Mitra S, Pande S. PMID: 42130550 [PubMed]
	Plasmon-Enhanced Magnetic Fluorescent Nanoprobe for Ultrasensitive Detection of Urinary miRNA-96 Enabling Early Diagnosis and Risk Stratification of Bladder Cancer. Anal Chem Zhang D, Li M, Yang B, Yan Z, Ding C, Huang Y. PMID: 42130209 [PubMed - as supplied by publisher]
	Exploring the Efficacy of Immunotherapy in Combination with Surgical Resection in High-risk Muscle-invasive Bladder Cancer. Iran J Allergy Asthma Immunol Li Z, Liu C, Wang H. PMID: 42130139 [PubMed - indexed for MEDLINE]
	Rezvilutamide in combination with androgen deprivation therapy (ADT) with or without docetaxel in the neoadjuvant treatment of oligometastatic prostate cancer (REDOOM): study protocol for an open-label, parallel-cohort, multicentre clinical study. BMJ Open Chen ZJ, Zhu XX, Huang H, Ding YZ, Zhuang YD, Wang L, Li P, Yu KY, Chen HD, Wang HL, Li HY, Cai B, Deng ZX, Pan Y, Yang Y, Li P, Huang KT, Ji XW, Lin Q, Chen W. PMID: 42129992 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 178248

Page 1 of 8913



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy